drugset / Trial / NCT00082927

Single-Dose Local Radiation Therapy Compared With Ibandronate in Treating Patients With Localized Metastatic Bone Pain

NCT00082927

Phase 3 Completed 580 enrolled Cancer Research UK
RandomizedOpen-labelSupportive care

Summary

RATIONALE: Ibandronate may be effective in reducing bone pain caused by metastatic cancer. Radiation therapy uses high-energy x-rays to damage tumor cells. It is not yet known whether ibandronate is more effective than standard treatment with radiation therapy in treating metastatic bone pain. PURPOSE: This phase III randomized clinical trial is studying ibandronate to see how well it works compared to single-dose local radiation therapy in treating patients with localized metastatic bone pain.

Timeline

Start
2003-04
Primary completion
Completion
2011-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Ibandronate Other / unclassified Intravenous